FHI vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 12, 2026

FHI

61.0
AI Score
VS
FHI Wins

CNS

58.5
AI Score

Investment Advisor Scores

FHI

61score
Recommendation
BUY

CNS

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI CNS Winner
Forward P/E 10.989 21.7865 FHI
PEG Ratio 2.2418 1.9462 CNS
Revenue Growth 13.1% 8.3% FHI
Earnings Growth 1.6% 6.5% CNS
Tradestie Score 61.0/100 58.5/100 FHI
Profit Margin 21.5% 27.5% CNS
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD FHI

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.